{
    "clinical_study": {
        "@rank": "23619", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating\n      patients who have metastatic prostate cancer that has not responded to hormone therapy."
        }, 
        "brief_title": "Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the efficacy of the combination of mitoxantrone and vinorelbine in terms of\n           response rate, progression free survival, overall survival, and quality of life in\n           patients with metastatic hormone refractory adenocarcinoma of the prostate.\n\n        -  Determine the toxicities of this treatment regimen in these patients.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive vinorelbine IV on days 1 and 8 and mitoxantrone IV on day 8. Treatment\n      repeats every 3 weeks for up to 9 courses in the absence of disease progression or\n      unacceptable toxicity.\n\n      Quality of life is assessed prior to treatment, prior to each course, and then at 2 months\n      after study completion.\n\n      Patients are followed every 3 months until disease progression.\n\n      PROJECTED ACCRUAL: A total of 14-39 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed stage IV hormone refractory adenocarcinoma\n             of the prostate\n\n          -  Progressive disease despite hormonal therapy or orchiectomy\n\n          -  No brain metastases\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 to 80\n\n        Performance status:\n\n          -  WHO 0-2\n\n        Life expectancy:\n\n          -  At least 3 months\n\n        Hematopoietic:\n\n          -  Absolute neutrophil count at least 2,000/mm^3\n\n          -  Platelet count greater than 100,000/mm^3\n\n          -  Hemoglobin greater than 9 g/dL\n\n        Hepatic:\n\n          -  Alkaline phosphatase no greater than 2 times upper limit of normal (ULN) (unless bone\n             metastasis)\n\n          -  Bilirubin less than 2 times ULN\n\n        Renal:\n\n          -  Creatinine less than 2 times ULN\n\n        Cardiovascular:\n\n          -  Adequate cardiac function\n\n        Other:\n\n          -  No other prior malignancy except curatively treated basal or squamous cell skin\n             cancer or carcinoma in situ of the cervix\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior chemotherapy\n\n        Endocrine therapy:\n\n          -  See Disease Characteristics\n\n          -  Prior corticosteroids allowed if started at least 8 weeks prior to study\n\n        Radiotherapy:\n\n          -  At least 8 weeks since prior extensive radiotherapy\n\n        Surgery:\n\n          -  See Disease Characteristics"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "August 3, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00006114", 
            "org_study_id": "CDR0000068126", 
            "secondary_id": [
                "FRE-GERCOR-NONA-U98-1", 
                "EU-20025"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "mitoxantrone hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "vinorelbine tartrate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vinorelbine", 
                "Mitoxantrone", 
                "Vinblastine"
            ]
        }, 
        "keyword": [
            "adenocarcinoma of the prostate", 
            "stage IV prostate cancer", 
            "recurrent prostate cancer"
        ], 
        "lastchanged_date": "February 26, 2011", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/FRE-GERCOR-NONA-U98-1"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France", 
                        "zip": "80054 Cedex 1"
                    }, 
                    "name": "Hopital Saint-Louis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clichy", 
                        "country": "France", 
                        "zip": "92110"
                    }, 
                    "name": "Hopital Gouin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Levallois-Perret", 
                        "country": "France", 
                        "zip": "92300"
                    }, 
                    "name": "Hopital Perpetuel Secours"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13385"
                    }, 
                    "name": "CHU de la Timone"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75007"
                    }, 
                    "name": "Hopital Laennec"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75571"
                    }, 
                    "name": "Hopital Saint Antoine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75970"
                    }, 
                    "name": "Hopital Tenon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "F-51100"
                    }, 
                    "name": "Polyclinique De Courlancy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Senlis", 
                        "country": "France", 
                        "zip": "60309"
                    }, 
                    "name": "C.H. Senlis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulon - Cedex", 
                        "country": "France", 
                        "zip": "83056"
                    }, 
                    "name": "Centre Hospitalier Intercommunal Toulon - La Seyne/Mer"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "official_title": "First Line Treatment of Metastatic Hormone Refractory Prostate Cancer With a Combination of Novantrone-Navelbine", 
        "overall_official": {
            "affiliation": "Centre Hospitalier Intercommunal Toulon - La Seyne Sur Mer", 
            "last_name": "Jean-Louis Wendling, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00006114"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 1999", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2000"
    }, 
    "geocoordinates": {
        "C.H. Senlis": "49.205 2.583", 
        "CHU de la Timone": "43.296 5.37", 
        "Centre Hospitalier Intercommunal Toulon - La Seyne/Mer": "43.124 5.928", 
        "Hopital Gouin": "48.905 2.305", 
        "Hopital Laennec": "48.857 2.352", 
        "Hopital Perpetuel Secours": "48.893 2.288", 
        "Hopital Saint Antoine": "48.857 2.352", 
        "Hopital Saint-Louis": "49.894 2.296", 
        "Hopital Tenon": "48.857 2.352", 
        "Polyclinique De Courlancy": "49.258 4.032"
    }
}